Serum concentration of 5-S-cysteinyldopa in patients with melanoma

European Journal of Clinical Investigation

Volumn 30, Issue 10, 2000, Pages 900-904

  Banfalvi T ^a   Gilde, K ^a   Boldizsar M ^a   Fejos Z ^a   Horvath B ^a   Liszkay, G ^a   Beczassy E ^a   Kremmer, T ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

5 S CD; Melanoma

Indexed keywords

CYSTEINYLDOPA; MELANIN;

ADULT; AGED; AMELANOTIC MELANOMA; ARTICLE; BLOOD LEVEL; CANCER STAGING; DIAGNOSTIC VALUE; DISEASE MARKER; EYE TUMOR; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK PATIENT; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; URINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYSTEINYLDOPA; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033784231     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00710.x     Document Type: Article

References (20)

1. Serum levels of S 100 protein and 5-S-cysteinyldopa as markers of melanoma progression
2. Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells
3. Evaluation of melanin-related metabolites as markers of melanoma progression
4. Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: Correlation with tumor burden
5. Determination of urinary 5-S-L-cysteinyl-L-dopa in serum by high performance liquid chromatography after prepurification with immobilized boric acid
6. Seasonal variations in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxyl acid in healthy Japanese
7. Evalutation of new putative tumor markers for melanoma
8. Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic naevus syndrome and normal subjects
9. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children
10. 5 years experience of 5-S-cysteinyldopa in melanoma diagnosis
11. Evaluation of the clinical usefulness of measuring urinary excretion of 5-S-cysteinyldopa in melanoma: Ten years experience of 50 patients
12. Serum levels of s-ICAM, and 5-S-cysteinyldopa as markers of melanoma progression
13. Clinical significance of S-100 protein assay in malignant melanoma
14. Correlation between lipid-associated sialic acid and tumor burden in melanoma
15. Clinical prognostic relevance of serum S-100b protein in malignant melanoma
16. The luminescence imunoassay S-100: A sensitive test to measure circulating S 100B: Its prognostic value in malignant melanoma
17. Prognostic value of serum S 100 protein b in malignant melanoma
18. MIA, a novel serum marker for progression of malignant melanoma
19. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibiting activity (MIA) reverse transcription